Back
X4 Pharmaceuticals Vs. Theriva Biologics Industry Stock Comparison
Sell
34
XFOR
X4 Pharmaceuticals
Last Price:
0.37
Seasonality Move:
2.21%
Sell
44
TOVX
Theriva Biologics
Last Price:
1.28
Seasonality Move:
98.81%
Sell
34
X4 Pharmaceuticals (XFOR)
is a Sell
Is X4 Pharmaceuticals a Buy, Sell or Hold?
- The current X4 Pharmaceuticals [XFOR] share price is $0.37. The Score for XFOR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- XFOR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy, Sell or Hold?
- The current Theriva Biologics [TOVX] share price is $1.28. The Score for TOVX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- TOVX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XFOR Stock Price Chart
What is X4 Pharmaceuticals's stock price today?
-
The X4 Pharmaceuticals share price today is $0.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XFOR is experiencing buying pressure, which is a positive indicator for future bullish movement.
TOVX Stock Price Chart
What is Theriva Biologics's stock price today?
-
The Theriva Biologics share price today is $1.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing slight buying pressure.
XFOR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 39.16 | Sell |
Chaikin Money Flow: | 1263637 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.4 - 0.58) | Sell |
Bollinger Bands (100): | (0.51 - 0.75) | Sell |
TOVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 36.52 | Sell |
Chaikin Money Flow: | 5109 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.3 - 1.86) | Sell |
Bollinger Bands (100): | (1.63 - 5.65) | Sell |
XFOR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.39 | Sell |
20-day SMA: | 0.48 | Sell |
50-day SMA: | 0.55 | Sell |
200-day SMA: | 0.84 | Sell |
8-day EMA: | 0.4 | Sell |
20-day EMA: | 0.46 | Sell |
50-day EMA: | 0.54 | Sell |
200-day EMA: | 0.77 | Sell |
TOVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.33 | Sell |
20-day SMA: | 1.6 | Sell |
50-day SMA: | 1.97 | Sell |
200-day SMA: | 6.78 | Sell |
8-day EMA: | 1.38 | Sell |
20-day EMA: | 1.55 | Sell |
50-day EMA: | 2.17 | Sell |
200-day EMA: | 6.2 | Sell |
X4 Pharmaceuticals Earnings Growth & XFOR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.44 per share.
Theriva Biologics Earnings Growth & TOVX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
X4 Pharmaceuticals Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Theriva Biologics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |